Gilenya

Drug Novartis Pharma AG
Total Payments
$109,264
Transactions
54
Doctors
11
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2017 $109,264 54 11

Payments by Nature

Nature of Payment Amount Transactions Share
Travel and Lodging $71,761 31 65.7%
Consulting Fee $35,917 13 32.9%
Food and Beverage $1,586 10 1.5%

Top Doctors Receiving Payments for Gilenya

Doctor Specialty Location Total Records
, MD, PHD Neurology Aurora, CO $18,658 6
, MD Neurology San Francisco, CA $16,766 6
, MD Neurology Los Angeles, CA $16,085 5
, MD Neurology Vienna, VA $15,371 6
, M.D Cardiovascular Disease Charlottesville, VA $9,872 4
, MD Neurology Rochester, MN $8,385 4
, M.D Neurology Rochester, MN $7,902 4
, MD Neurology Providence, RI $6,687 4
, MD, PHD Ophthalmology Newark, NJ $5,760 4
, MD Neurology Philadelphia, PA $3,420 9
, MD Neurology Boston, MA $359.21 2

About Gilenya

Gilenya is a drug associated with $109,264 in payments to 11 healthcare providers, recorded across 54 transactions in the CMS Open Payments database. The primary manufacturer is Novartis Pharma AG.

Payment data is available from 2017 to 2017. In 2017, $109,264 was paid across 54 transactions to 11 doctors.

The most common payment nature for Gilenya is "Travel and Lodging" ($71,761, 65.7% of total).